Glycosylated hemoglobin levels and clinical outcomes in nondiabetic patients with coronary artery disease
Open Access
- 1 April 2017
- journal article
- research article
- Published by Wolters Kluwer Health in Medicine
- Vol. 96 (17) , e6784
Abstract
A number of studies assessed the prognostic value of HbA1c level in nondiabetic patients with coronary artery disease (CAD). The purpose of this meta-analysis was to assess the association between the HbA1c level and clinical outcomes. We searched PubMed, EMBASE, MEDLINE, and the Cochrane Library from their inception to 10 April 2016. Studies evaluated the outcomes according to HbA1c levels in CAD patients without diabetes mellitus were eligible. Twenty studies involving 22,428 patients were included. In nondiabetic patients with CAD, a high HbA1c level was associated with a higher rate of long-term death (odds ratio 1.76, 95% confidence interval 1.44–2.16, P < .001), and myocardial infarction (MI, odds ratio 1.69, 95% confidence interval 1.07–2.67, P = .026), but not a higher rate of early deaths (odds ratio 1.08, 95% confidence interval 0.92–1.27, P = .359). These findings for death remained the same after sensitivity analyses and the trim and fill method, but the risk difference for MI became nonsignificant after adjustment for potential publication bias. Elevated HbA1c level increased the risks of long-term mortality and MI, but not the risk for early deaths in nondiabetic patients with CAD. High-quality large-scale studies with less bias are needed to confirm these findings.Keywords
This publication has 42 references indexed in Scilit:
- Impact of admission glycemia and glycosylated hemoglobin A1c on long-term clinical outcomes of non-diabetic patients with acute coronary syndromeJournal of Cardiology, 2014
- Prognostic significance of hemoglobin A1c level in patients hospitalized with coronary artery disease. A systematic review and meta-analysisCardiovascular Diabetology, 2011
- Prevalence of Diabetes among Men and Women in ChinaNew England Journal of Medicine, 2010
- Abnormal glucose regulation in patients with acute ST- elevation myocardial infarction-a cohort study on 224 patientsCardiovascular Diabetology, 2009
- Omega 3 fatty acids induce a marked reduction of apolipoprotein B48 when added to fluvastatin in patients with type 2 diabetes and mixed hyperlipidemia: a preliminary reportCardiovascular Diabetology, 2009
- Unrecognized glycometabolic disturbance as measured by hemoglobin A1c is associated with a poor outcome after acute myocardial infarctionAmerican Heart Journal, 2007
- Role of Insulin Resistance and Hyperglycemia in the Development of AtherosclerosisThe American Journal of Cardiology, 2007
- Hyperinsulinaemia is associated with increased long-term mortality following acute myocardial infarction in non-diabetic patients?European Heart Journal, 2004
- Quantifying heterogeneity in a meta‐analysisStatistics in Medicine, 2002
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986